SESSAREGO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 6.780
Totale 6.780
Nazione #
IT - Italia 6.780
Totale 6.780
Città #
Genova 5.534
Rapallo 748
Genoa 485
Bordighera 13
Totale 6.780
Nome #
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 172
Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course 156
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. 150
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 143
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study 142
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia 137
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 134
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 134
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis 131
Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease. 130
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 127
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 126
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 126
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 124
HMGA2 overexpression in plycythemia vera with t(12;21) (q14;q22) 124
Variant Philadelphia translocations in CML: correlation with fragile sites. 122
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 120
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 119
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemia. 117
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 116
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 114
Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy. 107
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 106
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. 104
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 104
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 104
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 104
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication 103
Unusual Ph translocations in CML: four new cases 102
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 100
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 100
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 100
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker 99
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 99
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 98
Masked Philadelphia chromosome caused by translocation (9;11;22) 98
Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia 96
Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities. 93
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time 92
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 90
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis 85
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 82
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 81
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor cell rescue for metastatic breast cancer 81
Preparation of colony stimulating activity from human leukemic urine: hydrophobic chromatography on propylamine-agarose. 81
Related Articles, Links Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. 78
Assocition of -318C/T and +49A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of italian patients with systemic sclerosis 78
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia. 77
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11 77
Urinary colony-stimulating factor in acute leukemia follow-up and correlation with various phases of the disease. 76
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia 74
Thrombocytosis in subjects with chronic myelocytic leukemia in blastic metamorphosis. Clinical remarks and therapeutic considerations (5 case reports). 73
Marked karyotype abnormalities in two cases of acute myelogenous leukemia. 73
Expression of erythroid acetylcholinesterase in the K-562 leukemia cell line 70
Erythroid differentiation of erythroleukemic line K562 (S) with arabinofuranosylcytosine: isolation of a non inducible clone. 70
Mixed chimerism after allogeneic marrow transplantation. 69
Demonstration of phosphoglucomutase 1 in a subclone of the K-562 cell line 69
Fibroblastoid colony-forming cells in myeloproliferative disorders. 68
Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization 68
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 67
Coincidence between fragile site expression and interstitial deletion ofchromosome 11 in a case of myelofibrosis 67
Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques. 67
Composition of human granulocytic colonies as a function of the purification stage of CSF. 65
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 63
Isolation and characterization of a K562 cell lineresistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction. 60
Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic response. 60
Regulation of acetylcholinesterase expression in the K-562 cell line 58
Marrow colony stimulating activity in chronic myelogenous leukemia. 55
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases. 53
Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease. 53
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score). 51
Totale 6.812
Categoria #
all - tutte 15.686
article - articoli 15.686
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019452 0 0 0 0 0 0 0 0 0 83 210 159
2019/20201.933 77 51 85 118 187 203 295 126 161 325 217 88
2020/2021454 19 52 24 37 30 38 21 50 54 47 35 47
2021/2022844 21 41 79 90 39 69 36 201 40 91 24 113
2022/2023890 93 71 15 98 159 169 0 62 148 5 66 4
2023/2024356 23 55 8 50 25 114 24 37 19 1 0 0
Totale 6.812